
Research
The lab is in the building.
What gets discovered here is meant to reach patients here first.
See the programmesThree foundations for research.
- 01Someone owns itA named principal investigator
- 02Ethics cleared itWith a regulatory route
- 03Evidence is publicIn an open register

Our research programmes.
- 01

Particle physics + FLASH
Beamline development, dosimetry and ultra-high dose-rate research.
- 02

Helium ion therapy
Helium ion feasibility, dosimetry and the AERB pathway.
- 03

RADSENSE-DX
Radiogenomic decision support with analytical and feasibility endpoints first.
- 04

Geriatric oncology
Assessment, toxicity prediction and de-escalation where de-escalation is right.
- 05

Longevity science
The Indian methylation clock, CHIP cohort, protocol registry and microbiome programme.
- 06

Immuno-radiotherapy
Dose, fractionation and sequence studied for immune priming.
- 07

Computational oncology + radiomics
Imaging phenotypes, adaptive replanning and accountable outcome modelling.
- 08

Sustainability in oncology
Carbon accounting for radiotherapy pathways and treatment closer to home.
- 09

Cell + gene therapy
GMP manufacture, CAR-T, NK-cell and exosome research with Regenerative Medicine.
- 10

Early detection
Multi-cancer methylation assays validated on Indian cohorts before broad claims.